Known targets — ChEMBL curated mechanism
PPARDPTGS1PTGS2dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Lysine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSR | P00390 | 1/20 | 0.67 |
| ▸ | ARG2 | P78540 | 4/20 | 0.43 |
| ▸ | ARG1 | P05089 | 3/20 | 0.43 |
| ▸ | NOS2 | P35228 | 5/20 | 0.42 |
| ▸ | NOS1 | P29475 | 4/20 | 0.42 |
| ▸ | NOS3 | P29474 | 3/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.42 |
| ▸ | BLM | P54132 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.39 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.39 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Lysine SCHEMBL746845 | 0.97 | GSR (0.71) | GSRARG2ARG1NOS2NOS1 | |
| Lysine SCHEMBL21816467 | 0.97 | GSR (0.71) | GSRARG2ARG1NOS2NOS1 | |
| Lysine SCHEMBL1537438 | 0.97 | GSR (0.71) | GSRARG2ARG1NOS2NOS1 | |
| Lysine SCHEMBL3358270 | 0.97 | GSR (0.71) | GSRARG2ARG1NOS2NOS1 | |
| Lysine SCHEMBL746846 | 0.97 | GSR (0.71) | GSRARG2ARG1NOS2NOS1 | |
| Lysine SCHEMBL5084119 | 0.97 | GSR (0.71) | GSRARG2ARG1NOS2NOS1 | |
| Lysine SCHEMBL1537434 | 0.97 | GSR (0.71) | GSRARG2ARG1NOS2NOS1 | |
| Lysine SCHEMBL23292473 | 0.92 | GSR (0.65) | GSRARG2ARG1NOS2NOS1 | |
| Lysine SCHEMBL15674546 | 0.92 | GSR (0.65) | GSRARG2ARG1NOS2NOS1 | |
| Lysine SCHEMBL8322630 | 0.92 | GSR (0.65) | GSRARG2ARG1NOS2NOS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11939608-B2 | Engineered heme-binding compositions and uses thereof | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 2024-03-26 | — | — | US | claimed |
| US-11312949-B2 | Engineered heme-binding compositions and uses thereof | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2022-04-26 | — | — | US | claimed |
| US-20220056089-A1 | ENGINEERED OPSONIN FOR PATHOGEN DETECTION AND TREATMENT | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2022-02-24 | — | — | US | claimed |
| US-11059873-B2 | Engineered opsonin for pathogen detection and treatment | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2021-07-13 | — | — | US | claimed |
| US-11059874-B2 | Engineered opsonin for pathogen detection and treatment | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2021-07-13 | — | — | US | claimed |
| EP-3773461-A1 | ENGINEERED TREATMENTS FOR HAIR REPAIR AND LONG-LASTING COLOR RETENTION | Massachusetts Institute of Technology (US) | 2021-02-17 | — | — | EP | claimed |
| CN-112118826-A | Engineered treatments for hair restoration and long lasting color maintenance | 麻省理工学院 | 2020-12-22 | — | — | CN | claimed |
| US-20200291083-A1 | ENGINEERED OPSONIN FOR PATHOGEN DETECTION AND TREATMENT | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2020-09-17 | — | — | US | claimed |
| US-20200095300-A1 | ENGINEERED OPSONIN FOR PATHOGEN DETECTION AND TREATMENT | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2020-03-26 | — | — | US | claimed |
| US-20190314260-A1 | ENGINEERED TREATMENTS FOR HAIR REPAIR AND LONG-LASTING COLOR RETENTION | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2019-10-17 | — | — | US | claimed |
| WO-2019200233-A1 | ENGINEERED TREATMENTS FOR HAIR REPAIR AND LONG-LASTING COLOR RETENTION | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2019-10-17 | — | — | WO | claimed |
| CN-102947341-B | Engineered opsonins for pathogen detection and treatment | 哈佛大学校长及研究员协会 | 2018-07-06 | — | — | CN | claimed |
| US-20180094035-A1 | ENGINEERED OPSONIN FOR PATHOGEN DETECTION AND TREATMENT | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2018-04-05 | — | — | US | claimed |
| US-9834597-B2 | Modified FC polypeptides, FC conjugates, and methods of use thereof | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2017-12-05 | — | — | US | claimed |
| US-20160200785-A1 | ENGINEERED OPSONIN FOR PATHOGEN DETECTION AND TREATMENT | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 2016-07-14 | — | — | US | claimed |
| US-9150631-B2 | Engineered opsonin for pathogen detection and treatment | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2015-10-06 | — | — | US | claimed |
| US-20150218258-A1 | MODIFIED FC POLYPEPTIDES, FC CONJUGATES, AND METHODS OF USE THEREOF | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2015-08-06 | — | — | US | claimed |
| US-11939608-B2 | Engineered heme-binding compositions and uses thereof | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 2024-03-26 | — | — | US | disclosed |
| WO-2002018438-A9 | MODIFIED PROTEINS, ISOLATED NOVEL PEPTIDES, AND USES THEREOF | UNIV AUSTRALIAN (AU) | 2002-05-30 | — | — | WO | disclosed |
| WO-2002018438-A1 | MODIFIED PROTEINS, ISOLATED NOVEL PEPTIDES, AND USES THEREOF | THE AUSTRALIAN NATIONAL UNIVERSITY (AU) | 2002-03-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11939608-B2 | Engineered heme-binding compositions and uses thereof | MB, MYOF, HMBS | GSR 518/4885ARG2 119/4885ARG1 623/4885 |
| US-20150218258-A1 | MODIFIED FC POLYPEPTIDES, FC CONJUGATES, AND METHODS OF USE THEREOF | FCGR3B, FCGR2A, FCGR1A | GSR 3579/4885ARG2 2600/4885ARG1 1859/4885 |
| US-20190314260-A1 | ENGINEERED TREATMENTS FOR HAIR REPAIR AND LONG-LASTING COLOR RETENTION | KRT18, CD44, EPCAM | GSR 462/4885ARG2 948/4885ARG1 751/4885 |
| US-11312949-B2 | Engineered heme-binding compositions and uses thereof | MB, MYOF, HMBS | GSR 518/4885ARG2 119/4885ARG1 623/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.